Month: March 2024

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors

Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the nomination to its Board of Directors of Dr. Theresa Heah. Dr. Heah is expected to join its Board of Directors immediately as an independent director. In addition to other Board duties Dr. Heah will serve on the newly created Clinical Development Committee of the Board. About Dr. Theresa Heah Dr. Heah recently served as the Chief Executive Officer and a member of the Board of Directors at Intergalactic Therapeutics an Apple Tree Partners company. She serves as an advisor to several venture capital firms and ophthalmology companies; and has recently become the Chief...

Continue reading

Total number of shares and voting rights in Zealand Pharma at March 31, 2024

Total number of shares and voting rights in Zealand Pharma at March 31, 2024

Company announcement – No. 21 / 2024 Total number of shares and voting rights in Zealand Pharma at March 31, 2024 Copenhagen, Denmark, March 31, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.  In Company announcement No. 11/2024 from March 5, 2024, and in company announcement No. 19/2024, from March 26,2024, Zealand announced an increase in share capital relating to exercise of employee warrants. Following these announcements, the table below lists the total number of...

Continue reading

CH Auto Technology Corporation Ltd. Completes Business Combination

CH Auto Technology Corporation Ltd. Completes Business Combination

BEIJING and NEW YORK, March 30, 2024 (GLOBE NEWSWIRE) — CH Auto Technology Corporation Ltd. (“CHATC”), a company formed under the laws of the Peoples Republic of China (“PRC”), an electric vehicle manufacturing and design service company based in China, and Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF), a Delaware corporation that was a publicly-traded special purpose acquisition company (“MCAF”), today announced that on March 28, 2024, the closing of their business combination transaction occurred, pursuant to an Agreement and Plan of Merger (as amended and restated on December 23, 2022 and further amended on March 1, 2023, the “Merger Agreement”) by and among the CHATC, MCAF, CH Auto, Inc., a Cayman Islands exempted company (“CH Auto”) and CH-Auto Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of CH...

Continue reading

CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants

CORRECTION — AEON Biopharma Announces Redemption of Public Warrants

IRVINE, Calif., March 30, 2024 (GLOBE NEWSWIRE) — Regarding a release issued under the same headline on March 29, 2024 by AEON Biopharma, Inc. (NYSE: AEON; AEON.WS), please note that in the first paragraph it incorrectly referenced March 29, 2024 as the Redemption Date. The Redemption Date is April 29, 2024. March 29, 2024 is the date on which the notice of redemption was delivered to warrant holders. The corrected release follows: AEON Biopharma, Inc. (NYSE: AEON; AEON.WS) (“AEON” or “the Company”), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s Class A common stock, par value...

Continue reading

Summit State Bank welcomes Dr. Frank Chong and James Finley to its Board of Directors

Summit State Bank welcomes Dr. Frank Chong and James Finley to its Board of Directors

SANTA ROSA, Calif., March 29, 2024 (GLOBE NEWSWIRE) — Summit State Bank (NASDAQ: SSBI) welcomes Dr. Frank Chong and James Finley, to its Board of Directors. Dr. Chong and Mr. Finley were elected to the Board of Directors at the Bank’s Board Meeting held on Monday, February 26, 2024. “We are pleased to welcome Dr. Chong and Mr. Finley as directors. Frank served as Superintendent/President of Santa Rosa Junior College, has a vast knowledge of the Sonoma County community and possesses strong leadership experience. Mr. Finley was selected for his knowledge of the financial services industry and business acumen,” stated Josh Cox, Chairman of the Board. Currently, Dr. Chong serves as President Emeritus retiring after 11 years at Santa Rosa Junior College. He was also the Deputy Assistant Secretary for Community Colleges at the United...

Continue reading

Battalion Oil Corporation Announces Fourth Quarter 2023 Financial and Operating Results

Battalion Oil Corporation Announces Fourth Quarter 2023 Financial and Operating Results

HOUSTON, March 29, 2024 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the fourth quarter of 2023. Key Highlights Approximately 41,000 net acres, 91% HBP in three contiguous blocks across Ward, Winkler and Pecos Counties with substantial remaining location inventory Brought previously announced AGI project online in Q1 2024 treating over 20 MMcf/d Recommenced drilling operations in Monument Draw in Q4 2023 to execute a six well program Completed two wells in Q4 2023, brought online in Q1 2024 under budget with strong initial results Drilled two additional wells in Q1 2024, currently completing Commenced drilling operations on two additional wells in Q1 2024, currently drilling ahead Generated full year sales volumes of 13,784...

Continue reading

Power REIT Receives Audit Opinion with Going Concern Explanation

Power REIT Receives Audit Opinion with Going Concern Explanation

Old Bethpage, New York, March 29, 2024 (GLOBE NEWSWIRE) — Power REIT (NYSE-AMEX: PW and PW.PRA) (“Power REIT” or the “Trust”), today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2023, which was filed on March 29, 2024 with the Securities and Exchange Commission, the audited financial statements contained an unqualified audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Trust’s ability to continue as a going concern. See further discussion in footnote 3 to the Trust’s financial statements included in the Company’s Annual Report on Form 10-K. This announcement is made pursuant to NYSE American LLC Company Guide Section 610(b), which requires public announcement of the receipt of an audit opinion containing...

Continue reading

Titan Medical Reports Fiscal Year 2023 Results

Titan Medical Reports Fiscal Year 2023 Results

TORONTO, Ontario, March 29, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the fiscal year ended December 31, 2023. Recent Activities: On August 14, 2023, the Company announced the appointment of Dr. Daniel O’Brien, MD, MBA, Ph.D to its Board of Directors. On August 21, 2023, the Company announced a licensing agreement with Auris Health, Inc., a Johnson & Johnson MedTech Company. On October 18, 2023, the Company announced it had changed its auditor from BDO Canada LLP to MNP LLP. On March 18, 2024, the Company announced it has entered into a definitive amalgamation agreement (the “Definitive Agreement”) with Conavi Medical Inc. (“Conavi”) to combine the companies in an all-stock transaction (the “Transaction”). Under the terms of the Definitive...

Continue reading

Rackspace Technology Announces Increase to Late Exchange Consideration for Exchange Offer Relating to its 3.50% First-Priority Senior Secured Notes due 2028

Rackspace Technology Announces Increase to Late Exchange Consideration for Exchange Offer Relating to its 3.50% First-Priority Senior Secured Notes due 2028

SAN ANTONIO, March 29, 2024 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT) (“Rackspace” or the “Company”), a leading end-to-end hybrid, multicloud, and AI technology solutions company, today announced that its indirect subsidiary Rackspace Finance, LLC (the “New Issuer”) is amending the terms of its previously announced offer (the “Amendment”) to eligible holders in respect of any and all of the 3.50% First-Priority Senior Secured Notes due 2028 (the “Existing Secured Notes”) issued by Rackspace’s indirect subsidiary Rackspace Technology Global, Inc., to (i) (A) exchange certain of those Existing Secured Notes for new 3.50% FLSO Senior Secured Notes due 2028 (the “Exchange Notes”) issued by the New Issuer and (B) have purchased for cancellation certain of those Existing Secured Notes by the New Issuer for cash (collectively,...

Continue reading

FitLife Brands Announces Fourth Quarter and Full-Year 2023 Results and Investor Conference Call

FitLife Brands Announces Fourth Quarter and Full-Year 2023 Results and Investor Conference Call

OMAHA, NE, March 29, 2024 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife,” the “Company,” or “We”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the year ended December 31, 2023.  The Company’s improved financial performance during the quarter and for the full year was driven primarily by the acquisition of Mimi’s Rock Corp. (“MRC”), which closed on February 28, 2023. Highlights for the year ended December 31, 2023 include: Total revenue was $52.7 million, an increase of 83% compared to $28.8 million in the prior year.  Online sales for the full year increased 309% to $33.4 million and represented 63% of total revenue compared to 28% in the prior year. Gross profit increased 78% to $21.4 million. Net income increased 20% to $5.3...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.